Gentiva Health Services, Inc. (NASDAQ:GTIV) closed almost 62% higher yesterday after the company confirmed that it had rejected a $533 million acquisition proposal from rival firm Kindred Healthcare, Inc. (KND). Kindred, which is interested in acquiring Gentiva to expand its services to the aging population Gentiva Health Services, Inc. (NASDAQ:GTIV) net profit margin is -34.70% and weekly performance is 71.16%. On last trading day company shares ended up $13.83. Analysts mean target price for the company is $9.58. Gentiva Health Services, Inc. (NASDAQ:GTIV) distance from 50-day simple moving average (SMA50) is 63.36%.
Pernix Therapeutics Holdings (NYSE:PTX) major shareholder James Edward Jr. Smith sold 289,400 shares of Pernix Therapeutics Holdings stock in a transaction that occurred on Wednesday, May 14th. The stock was sold at an average price of $5.47, for a total value of $1,583,018.00. Following the sale, the insider now directly owns 4,003,304 shares of the company’s stock, valued at approximately $21,898,073. Pernix Therapeutics Holdings Inc. (NASDAQ:PTX) shares advanced 15.03% in last trading session and ended the day on $6.43. PTX gross Margin is 48.30% and its return on assets is -10.30%.Pernix Therapeutics Holdings Inc. (NASDAQ:PTX) quarterly performance is 124.83%.
Novartis AG (NYSE:NVS) Friday said it would press ahead with further studies on its serelaxin heart failure drug after U.S. regulators said more evidence of its effectiveness was needed before they could grant approval. Novartis AG (ADR) (NYSE:NVS) shares moved up 0.77% in last trading session and was closed at $89.93, while trading in range of $89.23 – $89.96. Novartis AG (ADR) (NYSE:NVS) year to date (YTD) performance is 15.65%.
The Federal District Court of Delaware granted Edwards Lifesciences Corp (NYSE:EW) request for a preliminary injunction preventing sale of Medtronic’s CoreValve transcatheter aortic valve replacement (TAVR) product in the United States. The order was postponed for seven days while Medtronic asks the Federal Circuit Court of Appeals court for an emergency stay of that preliminary injunction, and appealed the decision. Edwards Lifesciences Corp (NYSE:EW) ended the last trading day at $85.87. Company weekly volatility is calculated as 1.33% and price to cash ratio as 10.89.Edwards Lifesciences Corp (NYSE:EW) showed a positive weekly performance of 2.37%.
Health Net (NYSE:HNT) had its price target upped by BMO Capital Markets from $35.00 to $38.00 in a research note issued to investors on Wednesday, AnalystRatings. Health Net, Inc. (NYSE:HNT) net profit margin is 1.50% and weekly performance is 5.85%. On last trading day company shares ended up $39.63. Analysts mean target price for the company is $38.67. Health Net, Inc. (NYSE:HNT) distance from 50-day simple moving average (SMA50) is 15.84%.